Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2

Monday, May 3, 2021 1 min read

Key Takeaway: Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2

Full Press Release Details

Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2.